Literature DB >> 5780393

Use of humoral or cellbound antibody to achieve depression of immunological reactivity.

H Wigzell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5780393     DOI: 10.1159/000386773

Source DB:  PubMed          Journal:  Antibiot Chemother


× No keyword cloud information.
  7 in total

1.  Suppression of the secondary immune response by specific antibody, when given together with the secondary antigenic stimulus.

Authors:  H Finger; H Hof; C H Wirsing; P Emmerling
Journal:  Experientia       Date:  1977-04-15

2.  [Inhibition of secondary 7S-antibody formation by antibody induced suppression of the primary immune reaction].

Authors:  P Emmerling; H Finger; L Eisele
Journal:  Z Med Mikrobiol Immunol       Date:  1970

3.  Activities of immunosuppressive agents in vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction.

Authors:  M A Bach; J F Bach
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

Review 4.  Antigen recognition by T-cells and its suppression. Significance and origin of rosette-forming cells.

Authors:  J F Bach
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

5.  Escape from antibody-mediated immune suppression in vitro by delayed-type hypersensitivity reaction.

Authors:  C C Muscoplat; T M Setcavage; Y B Kim
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

6.  In vitro induction of specific unresponsiveness of immunologically reactive, normal bone marrow cells.

Authors:  S K Singhal; H Wigzell
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

7.  Repeated dose multi-drug testing using a microfluidic chip-based coculture of human liver and kidney proximal tubules equivalents.

Authors:  Ni Lin; Xiaobing Zhou; Xingchao Geng; Christopher Drewell; Juliane Hübner; Zuogang Li; Yingli Zhang; Ming Xue; Uwe Marx; Bo Li
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.